Novophage
Novophage has developed a differentiated biological therapy to increase the efficacy of antibiotic treatments, to significantly slow the onset of antibiotic resistance, and to effectively treat biofilms.
| Startup type: | Competition Entry |
| Status: | Active |
| Publicity: | Stealth mode. No media please. |
OUR NEWS
Long ago
|
26 February 2009
Novophage updated their logo |
THINGS WE NEED
The Novophage team hasn't posted any needs yet.
COMMENTS (0)
Team (4)
View all
Followers (3)
View all-
-
-
Muhammad Ibrahim Rashid
CEO of RedPhages, Inc. Biotechnology graduate, currently enrolled at National University of Science and Technology NUST Pakistan in M. Phil Leading to PhD in Virology.